Ieq Capital, LLC Alkermes Plc. Transaction History
Ieq Capital, LLC
- $10.1 Billion
- Q4 2024
A detailed history of Ieq Capital, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Ieq Capital, LLC holds 36,763 shares of ALKS stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,763Holding current value
$1.16 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$919 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$599 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$410 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$400 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$290 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.19B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...